scholarly journals Retrospective Efficacy and Safety Analysis of Erlotinib (E), Pemetrexed (P) and Docetaxel (D) in Previously Treated Non-Small-Cell Lung Cancer Patients (NSCLC) without EGFR Mutation

2012 ◽  
Vol 23 ◽  
pp. ix437 ◽  
Author(s):  
J. Takeshita ◽  
N. Katakami ◽  
A. Nishiyama ◽  
H. Yoshioka ◽  
M. Iwasaku ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Egfr Mutation ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Previously Treated

scholarly journals Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients

2019 ◽  
Vol 10 (4) ◽  
pp. 775-781 ◽  
Author(s):  
Ayako Shiono ◽  
Kyoichi Kaira ◽  
Atsuto Mouri ◽  
Ou Yamaguchi ◽  
Kosuke Hashimoto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document